[HTML][HTML] A practical review of C-peptide testing in diabetes

E Leighton, CAR Sainsbury, GC Jones - Diabetes therapy, 2017 - Springer
C-peptide is a widely used measure of pancreatic beta cell function. It is produced in
equimolar amounts to endogenous insulin but is excreted at a more constant rate over a …

Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine

K Nimptsch, S Konigorski, T Pischon - Metabolism, 2019 - Elsevier
The global epidemic of obesity is a major public health problem today. Obesity increases the
risk of many chronic diseases, such as type 2 diabetes, coronary heart disease, and certain …

Addressing the perfect storm: biomarkers in obesity and pathophysiology of cardiometabolic risk

K Aleksandrova, D Mozaffarian, T Pischon - Clinical chemistry, 2018 - academic.oup.com
BACKGROUND The worldwide rise of obesity has provoked intensified research to better
understand its pathophysiology as a means for disease prevention. Several biomarkers that …

Mexico City normal weight children exposed to high concentrations of ambient PM2. 5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward …

L Calderón-Garcidueñas, M Franco-Lira… - Environmental …, 2015 - Elsevier
Millions of Mexico, US and across the world children are overweight and obese. Exposure to
fossil-fuel combustion sources increases the risk for obesity and diabetes, while long-term …

C‐peptide in diabetes: A player in a dual hormone disorder?

A Dakroub, A Dbouk, A Asfour… - Journal of cellular …, 2024 - Wiley Online Library
C‐peptide, a byproduct of insulin synthesis believed to be biologically inert, is emerging as a
multifunctional molecule. C‐peptide serves an anti‐inflammatory and anti‐atherogenic role …

[HTML][HTML] The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a …

ST Yan, J Sun, ZY Gu, XY Miao, LC Ma, BR Sun… - Cardiovascular …, 2022 - Springer
Background Recent literature reported the biological role of C-peptide, but this role is still
controversial and unclear. The primary aim of this study was to investigate associations …

[HTML][HTML] Dietary patterns and cardiometabolic and endocrine plasma biomarkers in US women

HB AlEssa, VS Malik, C Yuan, WC Willett… - The American journal of …, 2017 - Elsevier
Background: Healthful dietary patterns have been associated with lower risks of type 2
diabetes and coronary artery disease, but their relations with intermediate markers of …

[HTML][HTML] C-peptide: a mediator of the association between serum uric acid to creatinine ratio and non-alcoholic fatty liver disease in a Chinese population with normal …

C Ma, Y Liu, S He, J Zeng, P Li, C Ma, F Ping… - Frontiers in …, 2020 - frontiersin.org
Background The data on the relationship between normal-ranged serum uric acid (SUA), β-
cell function, and non-alcoholic fatty liver disease (NAFLD) are complicated and insufficient …

Association of C-peptide with diabetic vascular complications in type 2 diabetes

Y Wang, H Wan, Y Chen, F Xia, W Zhang, C Wang… - Diabetes & …, 2020 - Elsevier
Aim Fasting serum C-peptide is a biomarker of insulin production and insulin resistance, but
its association with vascular complications in type 2 diabetes mellitus (T2DM) has never …

C-peptide as a risk factor of coronary artery disease in the general population

A Cabrera de Leon, JG Oliva Garcia… - Diabetes and …, 2015 - journals.sagepub.com
Objective: To analyse the association between serum C-peptide and coronary artery
disease in the general population. Methods: Follow-up study of 6630 adults from the general …